1 CPD hour
Register now by clicking 'Add to basket' above.
The lung cancer landscape is changing. Screening (or case finding!) and immunotherapies are shifting the tides a little more in favour of patients and there are some important things we need to know in primary care.
Lung cancer historically is something we have seen as a death sentence. We have had a fairly nihilistic view of it and this has been understandable given only 5% are potentially curable at diagnosis. However, screening and novel therapies mean one-year survival is starting to creep up and a small sub-set of patients are living with lung cancer as a long term condition.
This webinar will cover:
- Lung cancer CT case finding (or screening!) is now a reality in many areas of the UK. Do you know how this works and what is means for you and your patients?
- Novel immunotherapies are an option for a small sub-group of patients with non-small cell lung cancer and can radically alter the prognosis. But, they have significant toxicities that can occur many months down the line and present to us in primary care – would you spot them and know what to do?
- How can we best support our patients with lung cancer: we offer some great resources.
Join our cancer course director, GP, David Plume and his guests in the Red Whale studio for the first in the second series of Red Whale cancer webinars in association with Macmillan Cancer Support to discuss this and much more. David will be joined by Dr Richard Simcock, ever-so-practical Consultant Clinical Oncologist from Brighton and Dr Tom Newsom-Davis, who is a Consultant Medical Oncologist at the Chelsea and Westminster specialising in thoracic malignancies and the vice chair of the British Thoracic Oncology Group Steering Committee. Between them, they should be able to answer all your questions!
Add to basket